THE EFFECTIVENESS OF TELEMEDICINE FOR BREAST CANCER DISEASE MANAGEMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS

Authors

  • Warattaya Wangwatcharakul Nonghin Hospital, Loei
  • Nattiya Kapol Department of Community Pharmacy, Faculty of Pharmacy, Silpakorn University, Sanamchandra Palace Campus, Nakhon Pathom
  • Waranee Bunchuailua Department of Community Pharmacy, Faculty of Pharmacy, Silpakorn University, Sanamchandra Palace Campus, Nakhon Pathom

DOI:

https://doi.org/10.14456/tbps.2018.21

Keywords:

telemedicine, effectiveness, breast cancer, systematic review, meta-analysis

Abstract

Breast cancer is an important public health problem affecting both physical and mental status of Thai women patients. Currently, telemedicine has been used in counseling and providing mental health support for breast cancer patients. There have been a number of studies revealing the effectiveness of telemedicine in various aspects. This study aimed to systematically review and conduct a meta-analysis on the effectiveness of telemedicine for breast cancer disease management. Published reports were searched through the electronic databases including PubMed, Scopus, Cochrane Library, and Thai databases from inception to January 2016. Randomized controlled trials reporting clinical or humanistic outcomes were selected. Results showed that 22 articles were identified consistent with inclusion criteria. Telemedicine was used to monitor symptoms, educate and advise the patients on self-care, and cope with problems through telephone, e-mail, website, and letter. Measured outcomes were mortality rates, adherence, recurrence, coping with problems, psychological and psychosocial status, and quality of life. The meta-analysis indicated no significant differences in the quality of life of the patients receiving telemedicine and those receiving the usual care practice, regarding the overall quality of life (standardized mean difference (SMD) = 0.10; 95%CI:   -0.14, 0.35; p-value = 0.41); role of functioning domain (MD = -2.12; 95% CI: -6.95, 2.70; p-value = 0.39); emotional functioning domain (MD = -1.62; 95% CI: -5.75, 2.51; p-value = 0.44), and fatigue domain (MD = 5.28; 95% CI: -2.45, 13.01; p-value = 0.18). However, further studies should be conducted on the use of telemedicine for breast cancer management as a supplement or a replacement of usual care.

 

References

1. American Cancer Society. Global Cancer Facts & Figures 3rd ed. Atlanta: American Cancer Society, Inc.; 2012.

2. World Health Organization. Cancer 2017 [homepage on the Internet]. c2017 [cited 2017 Nov 30]. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/

3. National Cancer Institute. Guidelines for Screening, Diagnosis, and Treatment of Breast Cancer. Nonthaburi: Department of Medicine, Ministry of Public Health; 2012 (in Thai).

4. Wannapornsiri C. Suffering and management on suffering of women with breast cancer receiving chemotherapy J Nur Health Sci. 2012;6(1):63-74.

5. Ashing‐Giwa KT, Padilla G, Tejero J, Kraemer J, Wright K, Coscarelli A, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology. 2004;13(6):408-28.

6. Ryu S. Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009 (Global Observatory for eHealth Series, Volume 2). Health Inform Res. 2012;18(2):153-155.

7. van den Berg N, Schumann M, Kraft K, Hoffmann W. Telemedicine and telecare for older patients—a systematic review. Maturitas. 2012;73(2):94-114.

8. Tangwuttanakidgul S. Telehealth project for rural. Nonthaburi: Ministry of Public Health; 2003 (in Thai).

9. Punsawat B CS, Chankate A, Punnakittikasem P, Tungkaprasert P, Laosirihongtong T. Innovative care for the elderly through telemedicine. Thai J Nur Coun. 2011;26(Special Issue ):5-16 (in Thai).

10. Jackson GL, Oddone EZ, Olsen MK, Powers BJ, Grubber JM, McCant F, et al. Racial differences in the effect of a telephone-delivered hypertension disease management program. J Gen Intern Med. 2012;27(12):1682-9.

11. Bailey Jr DE, Mishel MH, Belyea M, Stewart JL, Mohler J. Uncertainty intervention for watchful waiting in prostate cancer. Cancer nurs. 2004;27(5):339-46.

12. Okuyama S, Jones W, Ricklefs C, Tran ZV. Psychosocial telephone interventions for patients with cancer and survivors: a systematic review. Psychooncology. 2015;24(8):857-70.

13. Furlan AD, Malmivaara A, Chou R, Maher CG, Deyo RA, Schoene M, et al. 2015 updated method guideline for systematic reviews in the Cochrane Back and Neck Group. Spine. 2015;40(21):1660-73.

14. Higgins JPT TS, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.

15. Wheelock AE, Bock MA, Martin EL, Hwang J, Ernest ML, Rugo HS, et al. SIS. NET: A randomized controlled trial evaluating a web‐based system for symptom management after treatment of breast cancer. Cancer. 2015;121(6):893-9.

16. Freeman LW, White R, Ratcliff CG, Sutton S, Stewart M, Palmer JL, et al. A randomized trial comparing live and telemedicine deliveries of an imagery‐based behavioral intervention for breast cancer survivors: reducing symptoms and barriers to care. Psychooncology. 2015;24(8):910-8.

17. Ozkan B, Mentes S, Ozturk A, Soyuer S. Effects of follow-up by phone interview and anger management training provided to patients with breast cancer undergoing radiotherapy on levels of self-esteem, anger and depression. Int J Hematol Oncol. 2014;27(1):260-9.
18. Børøsund E, Cvancarova M, Moore SM, Ekstedt M, Ruland CM. Comparing effects in regular practice of e-communication and Web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial. J Med Internet Res. 2014;16(12).

19. Hayes SC, Rye S, DiSipio T, Yates P, Bashford J, Pyke C, et al. Exercise for health: a randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer. Breast Cancer Res Treat. 2013;137(1):175-86.

20. Ziller V, Kyvernitakis I, Knöll D, Storch A, Hars O, Hadji P. Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment-the COMPAS study. BMC cancer. 2013;13(1):407.

21. Belkora J, Stupar L, O’Donnell S, Loucks A, Moore D, Jupiter C, et al. Decision support by telephone: Randomized controlled trial in a rural community setting. Patient Educ Couns. 2012;89(1):134-42.

22. Høyer BB, Toft GV, Debess J, Ramlau-Hansen CH. A nurse-led telephone session and quality of life after radiotherapy among women with breast cancer: a randomized trial. Open Nurs J. 2011;5:31.

23. Djuric Z, Ellsworth JS, Weldon AL, Ren J, Richardson CR, Resnicow K, et al. A diet and exercise intervention during chemotherapy for breast cancer. Open Obes J. 2011;3:87.

24. Kimman M, Dirksen C, Voogd A, Falger P, Gijsen BC, Thuring M, et al. Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer. 2011;47(8):1175-85.

25. Kimman M, Dirksen C, Voogd A, Falger P, Gijsen BC, Thuring M, et al. Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2× 2 randomised controlled trial. Eur J Cancer. 2011;47(7):1027-36.

26. Marcus AC, Garrett KM, Cella D, Wenzel L, Brady MJ, Fairclough D, et al. Can telephone counseling post‐treatment improve psychosocial outcomes among early stage breast cancer survivors? Psychooncology. 2010;19(9):923-32.

27. Beaver K, Tysver-Robinson D, Campbell M, Twomey M, Williamson S, Hindley A, et al. Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ. 2009;338:a3147.

28. Heidrich SM, Brown RL, Egan JJ, Perez OA, Phelan CH, Yeom H, et al., editors. An individualized representational intervention to improve symptom management (IRIS) in older breast cancer survivors: three pilot studies. Oncology nursing forum; 2009: NIH Public Access.

29. Ell K, Vourlekis B, Xie B, Nedjat‐Haiem FR, Lee PJ, Muderspach L, et al. Cancer treatment adherence among low‐income women with breast or gynecologic cancer. Cancer. 2009;115(19):4606-15.

30. Budin WC, Hoskins CN, Haber J, Sherman DW, Maislin G, Cater JR, et al. Breast cancer: education, counseling, and adjustment among patients and partners: a randomized clinical trial. Nurs Res. 2008;57(3):199-213.

31. Gil KM, Mishel MH, Belyea M, Germino B, Porter LS, Clayton M. Benefits of the uncertainty management intervention for African American and White older breast cancer survivors: 20-month outcomes. Int J Behav Med. 2006;13(4):286-94.

32. Mishel MH, Germino BB, Gil KM, Belyea M, LaNey IC, Stewart J, et al. Benefits from an uncertainty management intervention for African–American and Caucasian older long‐term breast cancer survivors. Psychooncology. 2005;14(11):962-78.

33. Allen SM, Shah AC, Nezu AM, Nezu CM, Ciambrone D, Hogan J, et al. A problem‐solving approach to stress reduction among younger women with breast carcinoma. Cancer. 2002;94(12):3089-100.

34. Brown L, Payne S, Royle G. Patient initiated follow up of breast cancer. Psychooncology. 2002;11(4):346-55.

35. Sandgren AK, McCaul KD, King B, O'Donnell S, Foreman G, editors. Telephone therapy for patients with breast cancer. Oncology Nursing Forum; 2000.

36. Maunsell E, Brisson J, Deschênes L, Frasure-Smith N. Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life. J Clin Oncol. 1996;14(10):2747-55.

37. Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta‐analysis. Diabet Med. 2011;28(4):455-63.

38. Mishel MH, Belyea M, Germino BB, Stewart JL, Bailey DE, Robertson C, et al. Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects. Cancer. 2002;94(6):1854-66.

39. Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm. 2012;18(7):516-26.

Downloads

Published

2018-08-09

Issue

Section

Original Research Articles